NEKTAR THERAPEUTICS
NKTR · NASDAQ
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.
Market Data
Price
$72.07
+2.92 (+4.22%)
Market Cap$2.02B
P/E Ratio—
EPS$—
52W High$75.67
52W Low$6.48
Beta1.23
Data from Finnhub · Updated Mar 11, 2026